Tezepelumab Active Not Recruiting Phase 3 Trials for Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04851964Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis